Wells Fargo & Company Organogenesis Holdings Inc. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ORGO
# of Institutions
122Shares Held
60.5MCall Options Held
28.8KPut Options Held
27.9K-
Morgan Stanley New York, NY11.6MShares$34.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT11.5MShares$34.4 Million3.27% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$15.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$10.7 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.07MShares$9.19 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $391M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...